# Mifepristone Induction for Fetal Demise

> **NCT02620904** · PHASE4 · TERMINATED · sponsor: **Montefiore Medical Center** · enrollment: 9 (actual)

## Conditions studied

- Intrauterine Fetal Demise
- Fetal Death

## Interventions

- **DRUG:** Mifepristone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02620904
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07-14
- **Primary completion:** 2019-10
- **Final completion:** 2020-01
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** unable to recruit. Projected completion was 2018 however, enrollment and recruitment were difficult. The study was terminated due to inability to enroll.
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02620904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02620904, "Mifepristone Induction for Fetal Demise". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02620904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*